SMS Pharmaceuticals Ltd — Board/Management Information 2025

Jul 1, 2025

==> picture [241 x 156] intentionally omitted <==

Date: 1[st] July, 2025

To, The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051.

Security Code: 532815 Symbol: SMSPHARMA

Dear Sir/Madam,

Subject: Outcome of the Board Meeting - Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

We would like to inform you that the Board of Directors of the Company at their meeting held today i.e., 1[st] July, 2025, has inter- alia , transacted and approved the following item(s) of the Agenda:

• ❖ Approved the Re-appointment of Mr. Vamsi Krishna Potluri (DIN:06956498) as Whole Time Director of the Company designated as an Executive Director with effect from 01[st] July, 2025 for a period of 3 (three) years, subject to the approval of the shareholders at the ensuring general meeting of the Company.

Further, Mr. Vamsi Krishna Potluri is not debarred from holding the office of Director by virtue of any Order passed by the Securities and Exchange Board of India or any other such authority.

The details required to be furnished under SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 November 11, 2024 is annexed herewith as Annexure-I

The meeting commenced at 4:00 p.m and concluded at about 4.40 p.m

Please take the above intimation on your records.

Thanking you Yours faithfully

For SMS Pharmaceuticals Limited

THIRUMALESH Digitally signed by THIRUMALESH TUMMA TUMMA Date: 2025.07.01 16:59:35 +05'30'

Thirumalesh Tumma

Company Secretary

==> picture [241 x 156] intentionally omitted <==

Annexure-I

Re-appointment of Mr. Vamsi Krishna Potluri (DIN: 06956498), as an Executive Director of the Company.

Sr. No.		Particulars	Details
1.		Reason for change viz.~~appointment,~~ re-appointment,~~resignation, removal,~~ ~~death or otherwise~~	Mr. Vamsi Krishna Potluri has been re-appointed as Whole Time Director designated as an Executive Director of the Company.
2.		Date of~~appointment~~/re- appointment/~~cessation~~(as applicable) & Term of appointment/re- appointment	Re-appointed for further period of 3 (three) years commencing from 01st July, 2025 to 30thJune, 2028, subject to approval of the shareholders at the ensuing general meeting.
3.		Brief Profile (in case of appointment):	Mr. Vamsi Krishna Potluri is currently serving as the Executive Director of the Company. He holds a Bachelor's degree in Electrical and Electronics Engineering from BITS Pilani, Dubai, and a Master’s in Engineering Management from the Missouri University of Science and Technology, USA. He began his career with OHM Labs (Ranbaxy, USA) in supply chain operations before joining SMS Pharmaceuticals in 2014. In addition to his role as Executive Director, Mr. Vamsi Krishna also leads the Company’s marketing division and oversees research and development operations. Mr. Vamsi Krishna’s hands-on leadership, modern management style, and strong people skills, has been instrumental in fostering innovation, enhancing operational efficiency, and driving sustained growth across the organization.
4.		Disclosure of relationships between Directors (in case of appointment of a Director).	Mr. Vamsi Krishna Potluri is the eldest son of Mr. Ramesh Babu Potluri, Chairman and Managing Director of the Company and he is also brother of Mr. Trilok Potluri Non-Executive Director of the Company.